[1]Standiford TJ, Ward PA. Therapeutic targeting of acute lung injury and acute respiratory distress syndrome[J]. Transl Res, 2016, 167(1): 183-191.
[2]Liu H, Yu X, Yu S, et al. Molecular mechanisms in lipopolysaccharide-induced pulmonary endothelial barrier dysfunction [J]. Int Immunopharmacol, 2015, 29(2): 937-946.
[3]冯燕妮,潘红飞,梁玉美.呼吸窘迫综合征呼吸机相关性肺损伤应用肺保护性通气策略的疗效分析[J].中国医药导报,2013,10(18): 57-59.
[4]张红梅,王长虹,王峥涛.基于大鼠体内吸收分布的吴茱萸指标成分选择及测定[J].中成药, 2016, 38(7): 1538-1544.
[5]张栋健,李薇,何庆文,等.UHPLC-Q-TOF-MS分析枳壳炮制前后成分变化[J].中国中药杂志, 2016, 41(11): 2070-2080.
[6]Shimizu S, Miyamoto S, Fujii G, et al. Suppression of intestinal carcinogenesis in Apc-mutant mice by limonin [J].J Clin Biochem Nutr, 2015, 57(1):39-43.
[7]Yang N, Wang J, Liu C, et al. Berberine and limonin suppress IgE production by human B cells and peripheral blood mononuclear cells from food-allergic patients [J].Ann Allergy Asthma Immunol, 2014, 113(5):556-564.
[8]胡毅翔,蔡伟,张欢欢,等.基于肺部苦味受体抗哮喘天然活性成分筛选模型的建立与应用[J].中草药, 2016, 47(5): 775-780.
[9]周晓霞,张建情,刘春晓,等.白花前胡有效成分Pd-Ia对急性肺损伤的作用及机制研究[J].中国药理学通报, 2016, 32(8): 1165-1170.
[10]刘衍伶,邓林强,胡龙华, 等. 耐碳青霉烯类肺炎克雷伯菌耐药机制及呼吸机相关性感染的流行病学分析[J].中国临床药理学与治疗学, 2015, 20(10): 1137-1143.
[11]郭长满,陈丹,宋东,等.右美托咪定对小鼠肺血-再灌注损伤的保护作用[J].中国临床药理学与治疗学, 2016, 21(2): 145-149.
[12]Akbarshahi H, Rosendahl AH, Westergren-Thorsson G, et al. Acute lung injury in acute pancreatitis - Awaiting the big leap[J]. Res Med, 2012, 106: 1199-1210.
[13]畅毅平,彭鹏.炎症细胞因子与急性呼吸窘迫综合征的研究进展[J].临床肺科杂志, 2015, 20(2): 315-318.
[14]Samanta S, Rajasingh S, Cao T, et al. Epigenetic dysfunctional diseases and therapy for infection and inflammation [J]. Biochim Biophys Acta, 2017, 1863(2): 518-528.
[15]张利鹏,赵焱,刘国娟,等.乌司他丁通过干预p38MAPK/ERK信号通路减轻脓毒症性肺损伤[J].中国药理学通报,2016, 32(9):1311-1316.
[16]钟海潮,范芳华. IL-32在重症肺炎患者血浆中表达的临床意义及其机制探讨[J]. 中国临床药理学与治疗学, 2016, 21(9): 1024-1027.
[17]王檀,袁成波.温肺通痹颗粒治疗间质性肺疾病机理研究[J].长春中医药大学学报,2015, 31(3): 547-548.
[18]常秀娟,张帅,江益平,等.从细胞因子风暴探讨热毒宁注射液抗大鼠急性肺损伤作用机制[J].中草药,2015, 46(2):236-239. |